Related Experiment Video
Updated: Mar 23, 2026

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
6.9K
Detecting IOP Fluctuations in Glaucoma Patients.
Brenda Nuyen1, Kaweh Mansouri2
1Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, La Jolla, California, USA.
The Open Ophthalmology Journal
|March 26, 2016
Summary
Glaucoma management focuses on lowering intraocular pressure (IOP), but 24-hour IOP behavior is poorly understood. Continuous IOP monitoring may help detect undetected peaks and reduce vision loss.
Area of Science:
- Ophthalmology
- Medical Technology
Background:
- Lowering intraocular pressure (IOP) is crucial for glaucoma management.
- Current clinical practice relies on single IOP measurements, neglecting its 24-hour dynamic behavior.
- Most glaucoma patients exhibit peak IOP outside standard clinic hours, often undetected.
Purpose of the Study:
- To review current and future methods for 24-hour IOP assessment.
- To highlight the limitations of traditional single IOP measurements in glaucoma care.
- To explore the potential of continuous IOP monitoring in clinical practice.
Main Methods:
- Review of current and emerging technologies for continuous 24-hour IOP monitoring.
- Analysis of the shortcomings of traditional, single-point IOP measurement techniques.
- Discussion of the clinical implications of IOP fluctuations and peaks.
Main Results:
- Traditional single IOP measurements are insufficient for understanding glaucoma patients' 24-hour IOP profiles.
- Undetected IOP peaks outside clinic hours may contribute to disease progression despite treatment.
- Recent technological advancements enable continuous 24-hour IOP monitoring.
Conclusions:
- Continuous 24-hour IOP monitoring offers a more comprehensive understanding of IOP dynamics.
- Incorporating continuous IOP monitoring into clinical practice may improve glaucoma management.
- This approach has the potential to reduce glaucoma-related vision loss.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Ophthalmic Drug Delivery Systems
211
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
211

